Phreesia (PHR) Liabilities and Shareholders Equity (2019 - 2026)
Phreesia's (PHR) quarterly Liabilities and Shareholders Equity came in at $666.1 million in Q2 2026, up 66.37% year-on-year from $400.4 million in Q2 2025, and little changed quarter-over-quarter from $663.8 million in Q1 2026.
Phreesia (PHR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
Phreesia has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $666.1 million for Q2 2026.
- Liabilities and Shareholders Equity for Q2 2026 came in at $666.1 million, up 66.37% year-over-year; the trailing twelve-month figure through Apr 2026 was $2.2 billion (up 41.61% YoY), and the FY2026 annual result was $663.8 million, up 70.9% from the prior year.
- Liabilities and Shareholders Equity came in at $666.1 million for Q2 2026 at Phreesia, roughly flat from $663.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $666.1 million in Q2 2026 to a low of $340.4 million in Q3 2023.
- The 5-year median for Liabilities and Shareholders Equity is $392.9 million (2022), against an average of $424.8 million.
- Across the five-year window, Liabilities and Shareholders Equity dropped 25.16% in 2023 and soared 70.9% in 2026, its largest moves.
- Phreesia's Liabilities and Shareholders Equity stood at $397.3 million in 2022, then slipped by 5.7% to $374.6 million in 2023, then grew by 0.28% to $375.7 million in 2024, then increased by 12.71% to $423.5 million in 2025, then soared by 57.3% to $666.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $666.1 million (Q2 2026), $663.8 million (Q1 2026), and $423.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 728.77 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 1.02 Bn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 1.12 Bn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.84 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Phreesia | 569.84 Mn | 493.44 Mn | 113.28 Mn | 666.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 666.14 Mn |
| Jan 31, 2026 | 663.79 Mn |
| Oct 31, 2025 | 423.47 Mn |
| Jul 31, 2025 | 408.63 Mn |
| Apr 30, 2025 | 400.40 Mn |
| Jan 31, 2025 | 388.42 Mn |
| Oct 31, 2024 | 375.70 Mn |
| Jul 31, 2024 | 362.24 Mn |
| Apr 30, 2024 | 372.09 Mn |
| Jan 31, 2024 | 370.33 Mn |
| Oct 31, 2023 | 374.65 Mn |
| Jul 31, 2023 | 340.44 Mn |
| Apr 30, 2023 | 353.85 Mn |
| Jan 31, 2023 | 370.06 Mn |
| Oct 31, 2022 | 397.29 Mn |
| Jul 31, 2022 | 425.99 Mn |
| Apr 30, 2022 | 459.09 Mn |
| Jan 31, 2022 | 494.48 Mn |
| Oct 31, 2021 | 529.13 Mn |
| Jul 31, 2021 | 551.23 Mn |